Adefovir dipivoxil

98%

Reagent Code: #135280
label
Alias 9-[2-[bis(pivaloyloxy)methoxy]phosphorylmethoxy]ethyl-adenine; adephanvir dilipid
fingerprint
CAS Number 142340-99-6

science Other reagents with same CAS 142340-99-6

blur_circular Chemical Specifications

scatter_plot Molecular Information
Weight 501.48 g/mol
Formula C₂₀H₃₂N₅O₈P
badge Registry Numbers
MDL Number MFCD00869897
thermostat Physical Properties
Melting Point 99-103°C
inventory_2 Storage & Handling
Storage 2~8℃

description Product Description

Used to treat chronic hepatitis B virus (HBV) infection in adults with evidence of active viral replication and liver damage. It works by inhibiting the reverse transcriptase enzyme of HBV, reducing viral load and slowing disease progression. Typically prescribed when other treatments are not suitable or have failed. Requires regular monitoring of kidney function due to potential nephrotoxicity. Not recommended for use in HIV-HBV coinfected patients without antiretroviral therapy due to risk of developing HIV resistance.

format_list_bulleted Product Specification

Test Parameter Specification
Appearance WHITE TO PALE YELLOW SOLID
Purity (%) 97.5-100
MELTING POINT (C) 95-105

Available Sizes & Pricing

Size Availability Unit Price Quantity
1g
10-20 days ฿990.00
5g
10-20 days ฿3,200.00
Adefovir dipivoxil
No image available

Used to treat chronic hepatitis B virus (HBV) infection in adults with evidence of active viral replication and liver damage. It works by inhibiting the reverse transcriptase enzyme of HBV, reducing viral load and slowing disease progression. Typically prescribed when other treatments are not suitable or have failed. Requires regular monitoring of kidney function due to potential nephrotoxicity. Not recommended for use in HIV-HBV coinfected patients without antiretroviral therapy due to risk of developin

Used to treat chronic hepatitis B virus (HBV) infection in adults with evidence of active viral replication and liver damage. It works by inhibiting the reverse transcriptase enzyme of HBV, reducing viral load and slowing disease progression. Typically prescribed when other treatments are not suitable or have failed. Requires regular monitoring of kidney function due to potential nephrotoxicity. Not recommended for use in HIV-HBV coinfected patients without antiretroviral therapy due to risk of developing HIV resistance.

Mechanism -
Appearance -
Longevity -
Strength -
Storage -
Shelf Life -
Allergen(s) -
Dosage (Range) -
Dosage (Per Day) -
Mix Method -
Heat Resistance -
Stable in pH range -
Solubility -
Product Types -
INCI -

Purchase History for

Loading purchase history...